Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fredenhagen

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The Journal of Antibiotics|March 1, 1995
Paeciloquinones A, B, C, D, E and F: new potent inhibitors of protein tyrosine kinases produced by Paecilomyces carneus. I. Taxonomy, fermentation, isolation and biological activityF Petersen, A Fredenhagen, H Mett, et al.
Biopharmaceutics & Drug Disposition|March 20, 2020
Non-clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonistRenata Murgasova, Ester Tor Carreras, Martina Suetterlin-Hachmann, et al.
Arthritis and Rheumatism|August 1, 2007
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritisHolger Bang, Karl Egerer, Anke Gauliard, et al.
Chembiochem : a European Journal of Chemical Biology|October 23, 2018
Cladosporin Derivatives Obtained by Biotransformation Provide Guidance for the Focused Derivatization of this Antimalarial Lead CompoundAndreas Fredenhagen, Kirsten Schroer, Harald Schröder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Biocatalytic synthesis and structure elucidation of cyclized metabolites of the deacetylase inhibitor panobinostat (LBH589)Andreas Fredenhagen, Matthias Kittelmann, Lukas Oberer, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patientsOlga Derganova, Lorena Martinez-Gamboa, Karl Egerer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male SubjectsSu-Er W Huskey, Chun-qi Zhu, Andreas Fredenhagen, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The Journal of Antibiotics|March 1, 1995
Paeciloquinones A, B, C, D, E and F: new potent inhibitors of protein tyrosine kinases produced by Paecilomyces carneus. I. Taxonomy, fermentation, isolation and biological activityF Petersen, A Fredenhagen, H Mett, et al.
Biopharmaceutics & Drug Disposition|March 20, 2020
Non-clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonistRenata Murgasova, Ester Tor Carreras, Martina Suetterlin-Hachmann, et al.
Arthritis and Rheumatism|August 1, 2007
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritisHolger Bang, Karl Egerer, Anke Gauliard, et al.
Chembiochem : a European Journal of Chemical Biology|October 23, 2018
Cladosporin Derivatives Obtained by Biotransformation Provide Guidance for the Focused Derivatization of this Antimalarial Lead CompoundAndreas Fredenhagen, Kirsten Schroer, Harald Schröder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Biocatalytic synthesis and structure elucidation of cyclized metabolites of the deacetylase inhibitor panobinostat (LBH589)Andreas Fredenhagen, Matthias Kittelmann, Lukas Oberer, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patientsOlga Derganova, Lorena Martinez-Gamboa, Karl Egerer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2016
KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male SubjectsSu-Er W Huskey, Chun-qi Zhu, Andreas Fredenhagen, et al.
Pageof 5